Tyra Biosciences (TYRA) Current Leases (2020 - 2026)

Quarterly Current Leases rose 14.55% to $488000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $488000.0 through Mar 2026, up 14.55% year-over-year, with the annual reading at $472000.0 for FY2025, 14.56% up from the prior year.

Tyra Biosciences filings provide 7 years of Current Leases readings, the most recent being $488000.0 for Q1 2026.

  • Current Leases hit $488000.0 in Q1 2026 for Tyra Biosciences, up from $472000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $488000.0 in Q1 2026 and bottomed at $119000.0 in Q1 2022.
  • Average Current Leases over 5 years is $298294.1, with a median of $370000.0 recorded in 2024.
  • The largest annual shift saw Current Leases crashed 30.69% in 2022 before it skyrocketed 168.92% in 2024.
  • Tyra Biosciences' Current Leases stood at $140000.0 in 2022, then soared by 100.0% to $280000.0 in 2023, then soared by 47.14% to $412000.0 in 2024, then rose by 14.56% to $472000.0 in 2025, then grew by 3.39% to $488000.0 in 2026.
  • Per Business Quant, the three most recent readings for TYRA's Current Leases are $488000.0 (Q1 2026), $472000.0 (Q4 2025), and $456000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 83,991.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 720.00 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 45.66 Mn
10 Tyra Biosciences 2.03 Bn 2.03 Bn - 488,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 488,000.00
Dec 31, 2025 472,000.00
Sep 30, 2025 456,000.00
Jun 30, 2025 441,000.00
Mar 31, 2025 426,000.00
Dec 31, 2024 412,000.00
Sep 30, 2024 398,000.00
Jun 30, 2024 383,000.00
Mar 31, 2024 370,000.00
Dec 31, 2023 280,000.00
Sep 30, 2023 148,000.00
Jun 30, 2023 144,000.00
Mar 31, 2023 144,000.00
Dec 31, 2022 140,000.00
Sep 30, 2022 127,000.00
Jun 30, 2022 123,000.00
Mar 31, 2022 119,000.00
Dec 31, 2021 202,000.00
Sep 30, 2021 135,000.00
Dec 31, 2020 142,000.00